GlassScriptPhysician profile
Husam Mourtada
NPI 1114998671
$1,145.53
in general payments reported to CMS, 2019-2025
23 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Neuromusculoskeletal Medicine, Sports Medicine provider received nationally (typical 2025 total: $125).
See the full distribution for Neuromusculoskeletal Medicine, Sports Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $272 · 2021: $161 · 2022: $255 · 2023: $87.54 · 2024: $80.27 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $272.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $183.41 | 2019-2025 | Prolate, Nalocet, Tanlor |
| Spr Therapeutics, INC | $152.71 | 2020-2022 | |
| Pfizer INC. | $147.69 | 2019-2021 | |
| Medtronic, INC. | $79.45 | 2021 | |
| Abbvie INC. | $79.12 | 2021-2023 | |
| Collegium Pharmaceutical, INC. | $58.19 | 2024 | Belbuca |
| Grt US Holding, INC. | $57.51 | 2022 | |
| Nevro Corp. | $54.53 | 2019-2023 | Senza |
| Scilex Pharmaceuticals INC. | $52.67 | 2019 | |
| Hikma Pharmaceuticals USA | $49.46 | 2022 | |
| Tonix Medicines, INC. | $36.35 | 2025 | Tonmya |
| Alnylam Pharmaceuticals INC. | $31.52 | 2022-2025 | Onpattro |
| Avanos Medical | $20.04 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.58 | 2023 | Relistor |
| Depuy Synthes Sales INC. | $17.90 | 2024 | Monovisc, Orthovisc |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $17.68 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.29 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.17 | 2025 | |
| Biotissue Holdings INC. | $14.43 | 2023 | |
| Spinal Simplicity, LLC | $13.10 | 2022 | |
| Kaleo, INC. | $11.78 | 2019 | |
| Stimwave Technologies Incorporated | $10.77 | 2019 | |
| Laborie Medical Technologies Corp. | $4.18 | 2024 | Endosheath Technology |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Husam Mourtada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.